• RN Home
  • About RocketNews
    • About RocketNews
    • Article Submission Form
    • Commercial News Posting and Writing Services
    • Contact RocketNews
  • News Categories
    • Business
    • Climate Change
    • Education
    • Energy
    • Entertainment
    • Financial
    • Health
    • Jobs
    • Politics
    • Religion
    • Science
    • Sports
    • Stock Market News
    • Technology
    • Top Stories
    • Travel
    • World

Meta has struggled at selling anything other than ads. Will AI be different? – CNBC

by News Feed Editor | May 30, 2026 | Business

Meta has struggled at selling anything other than ads. Will AI be different?  CNBC Article Attribution | Read More at Article Source

Scott Bessent says US seized roughly $1B in Iranian crypto as regime nears ‘end of their tether’ – Fox Business

by News Feed Editor | May 29, 2026 | Business

Scott Bessent says US seized roughly $1B in Iranian crypto as regime nears ‘end of their tether’  Fox Business Article Attribution | Read More at Article Source

Peter Thiel’s move to Argentina reflects a growing trend among billionaires seeking a ‘plan B’ abroad – Business Insider

by News Feed Editor | May 29, 2026 | Business

Peter Thiel’s move to Argentina reflects a growing trend among billionaires seeking a ‘plan B’ abroad  Business Insider Article Attribution | Read More at Article Source

Opinion | It’s time for a new business plan for Minneapolis – Star Tribune

by News Feed Editor | May 29, 2026 | Business

Opinion | It’s time for a new business plan for Minneapolis  Star Tribune Article Attribution | Read More at Article Source

High School ‘Roadkill’ Side Hustle Turned Business: $600K a Year – entrepreneur.com

by News Feed Editor | May 29, 2026 | Business

High School ‘Roadkill’ Side Hustle Turned Business: $600K a Year  entrepreneur.com Article Attribution | Read More at Article Source

Replimune to resubmit twice-rejected drug for approval after FDA shakeup

by News Feed Editor | May 29, 2026 | Business

In this articleREPLFollow your favorite stocksCREATE FREE ACCOUNTThomas Fuller | Lightrocket | Getty ImagesReplimune plans to resubmit its melanoma drug to the Food and Drug Administration for review after a leadership exodus at the agency, the company said Friday....
« Older Entries
Next Entries »

Recent Posts

  • Rescues in eastern Syria after the Euphrates River bursts its banks
  • Iran war live: Lebanon accuses Israel of pursuing a ‘scorched earth policy’
  • Eric Cole gets another shot at his 1st PGA Tour win after 63 in 3rd round at Colonial
  • Christian Scott earns his first win, Hayden Senger hits first homer as Mets beat Marlins 6-1
  • Wong, Duran propel Red Sox to 9-1 victory over Guardians

Recent Comments

No comments to show.

About RN

Rocketnews is an aggregator of the top online news articles and stories from around the globe. Rocketnews uses news feeds from a variety on online news feed providers including Feedzilla, Yahoo, and the BBC. Addition news feed providers included online media suppliers, local and regional publications, industry journals, companies, governments, universities, PR companies, official organizations, associations, shopping guides and weblogs. Featured content providers include Reuters, Metacafe, News Corporation, About, BBC and The Sun.

Website Awards

2004 Webby Award Nomination

RocketNews nominated for a Webby Award

Search Engine Watch past honorable mention winner for Best News Search Engine.

More Info

About RocketNews

Contact RocketNews

COVID-19 Dashboard

Definitions and Terms

Privacy Policy

Site Design and Operation by Murray Owen LLC | A Web Development and Operations Company